Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers $49 weight-loss pill jolts everyone, except its stock

Hims & Hers sent a shockwave through the pharmaceutical industry on Thursday with its announcement of a weight-loss pill with…

Hims & Hers $49 Weight-Loss Pill Jolts Everyone, Except Its Stock

NEW YORK, Feb 6 (Reuters) - Hims & Hers sent a shockwave through the pharmaceutical industry on ?Thursday with its…

Hims & Hers Launches New Pill That Sends Shockwaves Across Weight-Loss Drugmakers Stocks

Hims & Hers Health, Eli Lilly, and Novo Nordisk shares all slid Thursday after Hims & Hers said it would…

Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill

Hims & Hers is making available a cheaper, compounded version of the Wegovy weight loss pill sold by Novo Nordisk,…

Novo Nordisk says it will take legal action after Hims & Hers reveals $49 copy of Wegovy pill

Hims said it would sell a copy of the newly launched weight loss pill for $49, far less than the…

Hims And Hers Broadens Care Model With GLP 1 Pill And Cancer Test

Hims & Hers Health (NYSE:HIMS) introduced a low cost compounded semaglutide pill for weight loss, offering a needle free alternative…

Dow falls sharply, Hims Wegovy rival, Nios profit outlook

Yahoo Finance Anchor Josh Lipton tracks todays top moving stocks and biggest market stories in this Market Minute, including the…

Novo Nordisk-Aktie -7%: Hims & Hers Health bringt wohl günstige Wegovy-Kopie - Auch Eli Lilly-Aktie unter Druck

Zuvor hatte die Nachrichtenagentur Reuters berichtet, dass das US-Telemedizinunternehmen Hims & Hers Health eine Nachahmer-Kopie der Abnehmpille Wegovy von Novo…

Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy. The news…

Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy.…

Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy…

Hims & Hers offers cheaper weight-loss pill in a shock to Novo

STORY: Shares of Novo Nordisk plunged again on Thursday after online telehealth firm Hims & Hers said it will offer…

Him & Hers plans to offer cheaper version of Wegovy pill, prompting Novo Nordisk to threaten legal action

A month after drugmaker Novo Nordisk launched its Wegovy pill, online health and wellness company Hims & Hers plans to…

Novo Nordisk klagt – Aktie auf tiefstem Stand seit 5 Jahren

Erst Preisdruck, dann Kurssturz – jetzt folgt die Eskalation. Novo Nordisk kündigt rechtliche Schritte an und geht offen auf Konfrontation…

Novo Nordisk klagt – Aktie auf tiefstem Stand seit 5 Jahren

Erst Preisdruck, dann Kurssturz – jetzt folgt die Eskalation. Novo Nordisk kündigt rechtliche Schritte an und geht offen auf Konfrontation…

Novo Nordisk Accuses Hims & Hers of ‘Illegal Mass Compounding’ Over Cheaper Wegovy Version

Hims & Hers said it would begin offering copies of Wegovy for an introductory price of $49 for the first…

Wegovy Copycat Is Coming From Hims & Hers. Novo Nordisk Stock Falls.

Hims & Hers’ new alternative to Novo Nordisk’s Wegovy pill will sell for $49 for the first month and $99…

Novo Nordisk to take legal action against Hims & Hers for Wegovy compounding

Novo Nordisk said on Thursday it would take legal action against Hims & Hers after the online telehealth company said…

Hims & Hers launch of compounded $49 Wegovy pill pummeled Novo Nordisk’s shares

The compounded pill is less expensive than the oral version of Wegovy, which costs $149 to get started.…

Why Eli Lilly Stock Just Dropped

Hims & Hers has a GLP-1 weight loss pill -- and its the cheapest one out there.…

Novo Nordisk hurt as rival Hims & Hers launches cheaper weight-loss pill

US telehealth group will sell product for $49 a month, a third that of its Danish competitor…

Hims & Hers Stock Jumps On Compounded Wegovy Launch - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health shares are trading higher Thursday after the company launched a compounded copy of the Wegovy pill…

VIEW Hims and Hers Healths compounded Wegovy pill offering fuels market jitters

Hims & Hers said it would begin offering compounded versions of Novo Nordisks Wegovy pill at an introductory price of…

Hims Knocks Off Novos Wegovy Pill For Just $49 A Month

Hims & Hers Health launched a knockoff version of Novo Nordisks already popular weight-loss pill on Thursday.…

Hims & Hers confirms $49 monthly starting price for Wegovy pill copy

Hims Hers (HIMS) confirmed that starting today, eligible customers can access treatment plans that include compounded semaglutide pills at…

Hims & Hers reportedly launches copy of Novo’s Wegovy pill

Hims & Hers (HIMS) stock jumps as the company plans to launch cheaper compounded versions of Novo Nodisks (NVO) Wegovy…

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

SAN FRANCISCO, February 05, 2026--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform,…

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion…

Hims & Hers launches compounded semaglutide pill as lower-cost weight loss option

Hims & Hers (NYSE:HIMS) has announced the launch of a compounded semaglutide pill designed for weight loss, providing an alternative…

Hims & Hers copies Novo Nordisks new Wegovy pill

Competition has already arrived for Novo Nordisks Wegovy pill, as telehealth company Hims & Hers launches a compounded version…

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

Hims Hers Health, Inc. (“Hims Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion…

More Options, More Support: New Compounded Semaglutide Pill from Hims & Hers

At Hims & Hers, we believe the best outcomes start with choice. That’s why across every speciality, we’ve always prioritized…

Grail multi-cancer test taps into Hims & Hers network

Grail has teamed up with telehealth company Hims & Hers to boost access to its recently filed Galleri blood test…

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory

We came across a?bullish thesis?on Hims & Hers Health, Inc. on Investment Edge’s Substack by David Vicuña. In this article, we…

Top Hims & Hers Executive Quietly Cashes Out in Eye-Catching Insider Trade

New insider activity at Hims & Hers Health ( ($HIMS) ) has taken place on February 4, 2026. Hims &…

Is Hims & Hers Health (HIMS) Attractive After The Recent Share Price Pullback

If you are wondering whether Hims & Hers Health at US$25.54 still offers value after its big run in recent…

Is Hims & Hers Health (HIMS) Starting To Look Attractive After Recent Share Price Slide?

If you are wondering whether Hims & Hers Health at around US$25.54 is starting to look interesting or stretched, you…

HUGE News: Hims & Hers Adds Cancer Testing to Labs Offering

Hims & Hers (NYSE: HIMS) announced today the launch of an early detection cancer test, bringing more value to its…

HUGE News: Hims & Hers Adds Cancer Testing to Labs Offering

Hims & Hers is moving beyond prescriptions to preventative testing.…

Hims & Hers to sell Grail’s Galleri multi-cancer blood test via its digital health platform

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech continues to…

Hims & Hers Shares In The Spotlight After Launching Multi-Cancer Test - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health shares are trending Wednesday after the company announced it launched access to the Hims & Hers…

Hims & Hers Offers Multi-Cancer Blood Screening Through New Partnership

Hims & Hers Health said Wednesday it launched a multi-cancer early detection blood test that can identify signals for…

Hims & Hers (HIMS) Launches Discounted Multi-Cancer Test

Key Takeaways: Hims & Hers Health (HIMS) introduces the Galleri multi-cancer early detection test, offering a $250…

Hims & Hers launches multi-cancer blood test screening for 50+ cancers By Investing.com

Hims & Hers launches multi-cancer blood test screening for 50+ cancers…

Hims & Hers rolls out GRAIL’s multi cancer screening test

Hims & Hers (HIMS) stock gains as the company company launches Galleri multi-cancer early detection test developed by GRAIL (GRAL).…

Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care

The company will offer access to Galleri ® , an innovative blood test from GRAIL, Inc. that screens for more…

Is HIMS Stock Undervalued in 2026 After a 32% Decline Last Year?

Hims & Hers Health stock could deliver 102% total upside and 20% annualized gains by 2029 as subscription growth scales…

Peak Retirement Planning Inc. Invests $2.84 Million in Hims & Hers Health, Inc. $HIMS

Peak Retirement Planning Inc. acquired a new stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in…

119,279 Shares in Hims & Hers Health, Inc. $HIMS Purchased by Pathway Capital Management LP

Pathway Capital Management LP bought a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free…

Are you ready for some drug ads?

Hims & Hers will run an advertisement for its telehealth platform during the Super Bowl.…